Sponsor:
Qurient Co., Ltd.
Code:
NCT05438420
Conditions
Esophageal Cancer
Gastric Cancer
Hepatocellular Cancer
Cervical Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Q702
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Qurient Co., Ltd. on 2024-03-12.